Insulin resistance, inflammation, and serum fatty acid composition

Diabetes Care

Volumn 26, Issue 5, 2003, Pages 1362-1368

  Fernández Real, José Manuel ^a   Broch, Montserrat ^b   Vendrell, Joan ^b   Ricart, Wifredo ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

15 TETRACOSENOIC ACID; ARACHIDIC ACID; BEHENIC ACID; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; INSULIN; INTERLEUKIN 6; LIGNOCERIC ACID; LINOLEIC ACID; OMEGA 6 FATTY ACID; UNCLASSIFIED DRUG;

ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; FATTY ACID BLOOD LEVEL; FEMALE; GAS LIQUID CHROMATOGRAPHY; HOMEOSTASIS; HUMAN; IMMUNOASSAY; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIPID COMPOSITION; LIPID DIET; MAJOR CLINICAL STUDY; MALE; OBESITY; REGRESSION ANALYSIS; SMOKING;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY CONSTITUTION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIETARY FATS; FATTY ACIDS; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; MALE; OBESITY; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; THINNESS;

EID: 0037836086     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.5.1362     Document Type: Article

References (35)

1. Fernández-Real JM, Ricart W: Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia 42:1367-1374, 1999
2. Feingold KR, Grunfeld C: Role of cytokines in inducing hyperlipidemia. Diabetes 41 (Suppl. 2):97-101, 1992
3. Papanicolau DA, Wilder RL, Manolagas SC, Chrousos GP: The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128:127-137, 1998
4. Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow RO, Jablons D: Interleukin-6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin-6 in cancer cachexia. Cancer Res 52:4113-4116, 1992
5. Nonogaki K, Fuller GM, Fuentes NL, Moser AH, Staprans I, Grunfeld C: Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 136:2143-2149, 1995
6. Stouthard JM, Romijn JA, Van der Poll T, Endert E, Klein S, Bakker PJ, Veenhof CH, Sauerwein HP: Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 268:E813-E819, 1995
7. Fernández-Real JM, Broch M, Vendrell J, Richart C, Ricart W: Interleukin 6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 85:1334-1339, 2000
8. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ, Wallace R: Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106:506-512, 1999
9. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334, 2001
10. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V: Inflammation, obesity, stress and coronary heart disease. Is interleukin-6 the link? Atherosclerosis 148:209-214, 2000
11. Hu FB, van Dam RM, Liu S: Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia 44:805-817, 2001
12. Meydani SN: Modulation of cytokine production by dietary polyunsaturated fatty acids. Proc Soc Exp Biol Med 200:189-193, 1992
13. Meydani SN, Endres S, Woods MM, Goldin BR, Soo C, Morrill-Labrode A, Dinarello CA, Gorbach SL: Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 121:547-555, 1991
14. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC, et al: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320:265-271, 1989
15. Vessby B: Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol 14:15-19, 2003
16. Lepage G, Roy CC: Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27:114-120, 1986, 1986
17. Fernández-Real JM, Molina A, Broch M, Ricart W, Gutiérrez C, Casamitjana R, Vendrell J, Soler J, Gómez-Sáez JM: Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes 48:1108-1112, 1999
18. 2 could be indicative of obesity in the Spanish population. Med Clin 117:681-684, 2001
19. Ma J, Folsom AR, Shadar E, Eckfeldt JH: Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. Am J Clin Nutr 62:564-571, 1995
20. Lee JY, Sohn KH, Rhee SH, Hwang D: Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through toll-like receptor 4. J Biol Chem 276:16683-16689, 2001
21. Khalfoun B, Thibault F, Watier H, Bardos P, Lebranchu Y: Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Med Biol 400B: 589-597, 1997
22. Loppnow H, Libby P: Comparative analysis of cytokine induction in human vascular endothelial and smooth muscle cells. Lymphokine Res 8:293-299, 1989
23. Iso H, Rexrode KM, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Hennekens CH, Willett WC: Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 285:304-312, 2001
24. Von Schacky C, Fischer S, Weber PC: Long term effects of dietary marine n-3 fatty acids upon plasma and cellular lipids, platelet function and eicosanoid formation in humans. J Clin Invest 76:1626-1631, 1985
25. Summers LKM, Fielding BA, Bradshaw HA, Ilic V, Beysen C, Clark ML, Moore NR, Frayn KN: Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 45:369-377, 2002
26. Vessby B, Gustafsson IB, Tengblad S, Boberg M, Andersson A: Desaturation and elongation of fatty acids and insulin action. Ann N Y Acad Sci 967:183-195, 2002
27. Fernández-Real JM, Vayreda M, Richart C, Gutiérrez C, Broch M, Vendrell J, Ricart W: Circulating interleukin 6 levels, blood pressure and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 86:1154-1159, 2001
28. De Caterina R, Liao JK, Libby P: Fatty acid modulation of endothelial activation. Am J Clin Nutr 71:213-223, 2000
29. Stouthard JM, Levi M, Hack CE, Veenhof CH, Romijn HA, Sauerwein HP, van der Poll T: Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Hemost 76:738-742, 1996
30. Seino Y, Ikeda U, Ikeda M, Yamamoto K, Misawa Y, Hasegawa T, Kano S, Shimada K: Interleukin-6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 6:87-91, 1994
31. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767-1772, 2000
32. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:731-733, 1998
33. Kuller LH, Tracy RP, Shaten J, Meilahn EN, for the MRFIT Research Group: Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 144:537-547, 1996
34. Miettinen TA, Naukkarinen V, Huttunen JK, Mattila S, Kumlin T: Fatty acid composition of serum lipids predicts myocardial infarction. BMJ 285:993-996, 1982
35. Han SN, Leka LS, Lichtenstein AH, Ausman LM, Schaefer EJ, Meydani SN: Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J Lipid Res 43:445-452, 2002